XML 88 R18.htm IDEA: XBRL DOCUMENT
v3.21.2

Discontinued Operations | 12 Months Ended
--- | ---
Mar. 31, 2021
Discontinued Operations and Disposal Groups [Abstract] |
Discontinued Operations | Note 6—Discontinued Operations As a result of the Sumitomo Transaction Agreement, see Note 5, “Sumitomo Transaction Agreement,” the financial results of the Sumitovant Vants are presented as “Income from discontinued operations, net of tax” in the accompanying consolidated statements of operations for the year ended March 31, 2020. There were no operating results from discontinued operations for the year ended March 31, 2021. The following table presents components of discontinued operations included in “Income from discontinued operations, net of tax” for the year ended March 31, 2020 (in thousands).
|  | Year Ended March 31, 2020 |
Operating expenses: |  |  |  |
Research and development |  | $ | 265,452 |
General and administrative |  |  | 119,885 |
Total operating expenses |  |  | 385,337 |
Loss from operations |  |  | (385,337 | )
Gain on sale of business |  |  | (1,985,949 | )
Interest income |  |  | (2,305 | )
Interest expense (1) |  |  | 13,733 |
Other expense |  |  | 8,866 |
Income from discontinued operations before income taxes |  |  | 1,580,318 |
Income tax expense |  |  | 1,892 |
Income from discontinued operations, net of tax |  | $ | 1,578,426 |
Loss from discontinued operations before income taxes attributable to noncontrolling interests |  | $ | (141,783 | )
Income from discontinued operations before income taxes attributable to Roivant Sciences Ltd. |  |  | 1,722,101 |
Income from discontinued operations before income taxes |  | $ | 1,580,318 |
(1) | Interest expense consists of interest payments related to outstanding debt held by Myovant and Urovant as well as the associated non-cash amortization of debt discounts and issuance costs.
In the accompanying consolidated statements of cash flows, the cash flows from discontinued operations are not separately classified. The significant cash flow items from discontinued operations were as follows (in thousands):
|  | Year Ended March 31, 2020 |
Gain on sale of business |  | $ | (1,985,949 | )
Share-based compensation |  | $ | 54,821 |
Acquired in-process research and development |  | $ | 16,405 |

X
- References No definition available. + Details
Name: | us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -URI http://asc.fasb.org/topic&trid=2155823 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -URI http://asc.fasb.org/subtopic&trid=2122178 + Details
Name: | us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration